PHYSICAL SCIENCES INC. — Department of Health and Human Services SBIR Phase II: The development of biologic drugs for cancer treatment often requires formulations that mu

Description

The development of biologic drugs for cancer treatment often requires formulations that must be lyophilized to produce stable drug products. The process of developing a drug formulation and freeze drying process begins with laboratory experiments followedby scale-up to pilot and production scale lyophilizers. A major challenge during early formulation and lyophilization process development is the cost and limited supply of API available for development and the lack of representative small scale lyophilizerthat emulates a production scale dryer. Current laboratory dryers hold hundreds of vials and their operation and product drying behavior with jsut a few vials is different than with a full load of vials due to highly atypical radiation heat transfer. Theprocess information gathered drying a few vials in a standard laboratory dryer is relatively useless. The goal of this Phase I SBIR program is to design, fabricate, test and apply a mini lyophilizer that dries one to seven product vials under heat and masstransfer conditions typicaly encountered in larger production freeze dryers. The mini lyophilizer will be outfitted with process analytical technology tools that enable the use of scientific and engineering principles for successful scale up and economically viable drug product manufacturing. PUBLIC HEALTH RELEVANCE